Higher dose of electroconvulsive therapy works better to relieve depression

May 14, 2000

More powerful shocks of electroconvulsive therapy (ECT) speed relief of depression, researchers at Wake Forest University Baptist Medical Center and two other centers report in the May 15 issue of Archives of General Psychiatry, an American Medical Association publication.

At the same time, the larger shocks increase temporary loss of memory -- even for autobiographical facts, said W. Vaughn McCall, M.D., M.S., associate professor of psychiatry and behavioral medicine and lead investigator.

ECT, also known as shock treatment, has been used for years for patients who have what psychiatrists refer to as "major depressive episode." In more recent years, doctors have been testing whether applying a shock to just one side of the brain would relieve depression as well as applying ECT to both sides of the brain, while decreasing side effects.

At lower doses, "the antidepressant efficacy [of treating one side of the brain] has been low compared with bilateral ECT," McCall reported.

The new study compared patients given a moderate ECT dose with those given high-dose treatments, both only on the right side. The moderate dose was a variable amount, linked to 2.25 times the patient's "initial seizure threshold," the point at which shock induces a convulsion. The high dose was the same fixed amount for all patients.

The team reported that 66.7 percent of patients on the high dose treatment experienced relief of depression, compared to 38.9 percent of those on the moderate, variable dose.

Nonetheless, nine of the 72 patients studied were removed from the protocol "because of insufficient clinical response" and switched to the more traditional bilateral ECT.

The investigators determined that the higher the ECT dose, the greater the efficacy.

"The difference in antidepressant efficacy for the two groups has practical implications," McCall said. A typical course of therapy is six to eight treatments at the rate of three per week. The patients on the moderate dose ended up with an average of 1 1/2 additional ECT treatments, which means their complete course of ECT lasted an additional 3 1/2 days.

The team found temporary memory disturbances, using a test called the Mini Mental State Exam, among both groups. The rate of cognitive disturbance among the high dose group was 30.3 percent, compared to just 6.7 percent among the moderate group. It also took the high dose group longer to get reoriented.

And the high dose group had more trouble with autobiographical items. "Typical examples of autobiographic memory loss include inability to remember events in the last few weeks," said McCall. "For example, if a person had ECT during May, then their memory of what had happened in the months of April and May would be at risk of being forgotten, perhaps forever. In contrast, more distant memories, such as Thanksgiving or Christmas, are likely to be preserved."

McCall reported that increasing the ECT dose had an bigger effect on memory than on depression. "We routinely discuss these memory effects with patients prior to ECT, and most patients find this an acceptable trade for a chance at having their depression relieved."

Modern ECT is vastly different from ECT of the 50s and 60s as portrayed in the movies. It is administered under anesthesia and the convulsion is extremely limited, causing only a slight tremor in the patient that can barely be seen.
-end-
The researchers also included David M. Reboussin, Ph.D., of the Department of Public Health Sciences, Richard D. Weiner, M.D., Ph.D., of the Department of Psychiatry at Duke University School of Medicine, and Harold A. Sackeim, Ph.D., of the Departments of Psychiatry and Radiology at the College of Physicians and Surgeons, Columbia University.

Wake Forest Baptist Medical Center

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.